Navigation Links
Preview of oral presentations at the 1st IOF-ESCEO Pre-Clinical Symposium

Registrants to the largest European clinical and research bone meeting - the European Congress on Osteoporosis & Osteoarthritis (ECCEO11-IOF) from March 23-26, 2011 - will receive free registration to the 1st IOF-ESCEO Pre-Clinical Symposium from March 22-23.

The IOF-ESCEO Pre-Clinical Symposium showcases new research at the cutting edge of basic and translational bone science. It will feature:

  • Eight plenary lectures by speakers E. Wagner, J.-P. David, A. Teti, Ph. Clzardin, M. Kassem, P. Bianco, T. Schinke and G. Karsenty
  • Meet-the-Faculty sessions: How to write a grant, C. Cooper; How to write a manuscript, G. Karsenty; How to build up a lecture, E. Wagner; Women in academic careers, A. Teti
  • Twenty-eight selected oral presentations (7 hours!).

Here's a sneak preview of 10 of the 28 orals and speakers:

  • DLK1/FA1 regulates the early chondrogenesis during embryonic endochondral bone formation process and its expression is modulated by TGF-β1 signaling pathway - B. Abdallah

  • Genetic variation in the LRP4 gene influences bone mineral density and hip geometry while missense mutations cause sclerosteosis - E. Piters

  • Sclerostin antibody treatment enhances fracture healing and increases bone mass and strength in non-fractured bones in an adult rat closed femoral fracture model - H. Ke

  • Genome wide association study identifies seven loci that account for 86% of the population attributable risk of paget's disease of bone - O. Albagha

  • Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor - J. Tuckermann

  • MicroRNA-138 targets focal adhesion kinase and regulates In Vivo - M. Kassem

  • Control of bone resorption by semaphorin 4D is dependent on ovarian function - I. Machuca-Gayet

  • Iron overload stimulates osteoclast differentiation of murine osteoclast progenitor RAW 264.7 Through the production of reactive oxygen species - J. Peng

  • MHC class II transactivator: a novel regulator of osteoclast differentiation and bone homeostasis co-opted from adaptive immunity - S. Cenci

  • Strontium ranelate inhibits key factors affecting bone remodelling in human osteoarthritic subchondral bone osteoblasts - J. Martel-Pelletier

Visit for the complete list of 28 oral presentations and 8 plenary lectures.

We look forward to seeing you in Valencia!


Contact: L. Misteli
International Osteoporosis Foundation

Related biology news :

1. Innerscope Research(R) Uses Same-Day Results From Biometric Study to Identify Key Themes, Styles Behind Effective, Engaging Speaker Presentations
2. Announcing the 1st IOF-ESCEO Pre-Clinical Symposium
3. Symposium to provide forum for best pre-clinical and translational bone research
4. A missing enzyme conveys major heart protection in pre-clinical work
5. Alzheimers disease therapeutic prevents long-term damage from TBI in pre-clinical studies
6. AAAS Symposium: New research facilitates scientific knowledge transfer
7. WidePoint Corporation Sponsors Identity Protection and Management Symposium, February 3, 2011
8. WidePoint Corporation Sponsors Identity Protection and Management Symposium, February 3, 2011
9. Oil spill symposium to convene scientists, media, policymakers and community leaders
10. Graduate physics students wins top honors in superconductivity symposium
11. Symposium marks milestones in honey bee management, research
Post Your Comments:
(Date:11/10/2015)... NEW YORK , Nov. 10, 2015 /PRNewswire/ ... refers to behavioral biometrics that helps to identify ... prevent fraud. Signature is considered as the secure ... for the identification of a particular individual because ... offers more accurate results especially when dynamic signature ...
(Date:11/9/2015)... Calif. , Nov. 9, 2015  Synaptics Inc. ... interface solutions, today announced broader entry into the automotive ... solutions that match the pace of consumer electronics human ... biometric sensors are ideal for the automotive industry and ... Europe , ...
(Date:11/2/2015)... , Nov. 2, 2015  SRI International has been ... provide preclinical development services to the National Cancer Institute ... will provide scientific expertise, modern testing and support facilities, ... preclinical pharmacology and toxicology studies to evaluate potential cancer ... The PREVENT Cancer Drug Development Program is an ...
Breaking Biology News(10 mins):
(Date:11/27/2015)... ... November 27, 2015 , ... Pittcon ... over 2,000 technical presentations offered in symposia, oral sessions, workshops, awards, and posters. ... a wide range of applications such as, but not limited to, biotechnology, biomedical, ...
(Date:11/25/2015)... -- PharmAthene, Inc. (NYSE MKT: PIP) announced  today that its ... (Rights Plan) in an effort to preserve the value ... 382 of the Internal Revenue Code (Code). ... its NOLs could be substantially limited if the Company ... of the Code. In general, an ownership change occurs ...
(Date:11/25/2015)... /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS; TSX: AEZ) ... remain fundamentally strong and highlights the following developments: ... DSMB recommendation to continue the ZoptEC Phase 3 ... final interim efficacy and safety data , ... with heavily pretreated castration- and Taxane-resistant prostate cancer ...
(Date:11/24/2015)... , Nov. 24, 2015  Asia-Pacific (APAC) holds ... organisation (CRO) market. The trend of outsourcing to ... margins but higher volume share for the region ... scale, however, margins in the CRO industry will ... Market ( ), finds that the ...
Breaking Biology Technology: